Keep Mifepristone Available by Mail and Telehealth

Mifepristone works without surgery for 97.4% of patients in U.S.

A letter to your members of Congress. Facts checked September 24, 2026.

The explainer behind this letter Mifepristone Is the abortion pill legal, how safe it is, and the fights over access

The Letter

Subject Oppose restoring in-person pickup for mifepristone

Mifepristone is one of the most-studied drugs in America, and I am asking you to help keep it available by telehealth and mail.

In U.S. clinical trials, 97.4% of patients needed no surgery, and serious reactions were reported in under 0.5%. More than a quarter of abortions in 2025 began with a telehealth visit. For people in rural areas, or who cannot take days off to drive to a clinic, mail is how this care reaches them. The same drug is used to manage miscarriage.

Louisiana is asking the courts to bring back the in-person pickup rule nationwide, and the FDA has opened a review with no end date. Decisions about this drug should rest on evidence, not on politics.

Please state publicly that you oppose restoring the in-person requirement for mifepristone.

Send Your Letter

Resistbot

Copy the letter above and fax, email, or mail it to your state or federal representatives.

Text RESIST to 50409 to get started

Send via Resistbot

Democracy.io

Copy the letter above and email it to your House and Senate members.

Free tool from the Electronic Frontier Foundation. Federal officials only.

Send via Democracy.io

Call Your Representative

U.S. Capitol switchboard: (202) 224-3121

I am a constituent calling to ask the representative to help keep mifepristone available by telehealth and mail.
In U.S. clinical trials, 97.4% of patients needed no surgery, and serious reactions were under 0.5%.
More than a quarter of abortions in 2025 began with a telehealth visit. Louisiana is asking the courts to bring back in-person pickup nationwide.
Please state publicly that you oppose restoring the in-person requirement for mifepristone.

Calls get logged by topic. Volume drives the briefing.

The Facts Behind the Ask

97.4% of U.S. trial patients needed no surgery to complete a medication abortion (source)
28% of U.S. abortions in 2025 began with a telehealth visit (source)
May 14, 2026 Supreme Court stayed the Fifth Circuit order restoring in-person pickup (source)

See every letter you can send